BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21126705)

  • 1. Medical treatment of GORD. Emerging therapeutic targets and concepts.
    Zerbib F
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):937-46. PubMed ID: 21126705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutics for gastro-esophageal reflux symptoms.
    Zerbib F; Simon M
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):533-41. PubMed ID: 23121276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients?
    Kahrilas PJ; Boeckxstaens G
    Gut; 2012 Oct; 61(10):1501-9. PubMed ID: 22684485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pharmacologic approaches in gastroesophageal reflux disease.
    Armstrong D; Sifrim D
    Gastroenterol Clin North Am; 2010 Sep; 39(3):393-418. PubMed ID: 20951909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological targets in gastro-oesophageal reflux disease.
    Piche T; Galmiche JP
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):333-41. PubMed ID: 16364047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of gastro-esophageal reflux disease: the new kids to block.
    Blondeau K
    Neurogastroenterol Motil; 2010 Aug; 22(8):836-40. PubMed ID: 20663054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.
    Tonini M; De Giorgio R; De Ponti F
    Drugs; 2004; 64(4):347-61. PubMed ID: 14969571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
    Johnson DA; Levy BH
    Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflux inhibitors: a new approach for GERD?
    Boeckxstaens GE
    Curr Opin Pharmacol; 2008 Dec; 8(6):685-9. PubMed ID: 18771751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel treatments of GERD: focus on the lower esophageal sphincter.
    Lehmann A
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():103-10. PubMed ID: 18924449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for gastroesophageal reflux disease.
    Boeckxstaens GE
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options for refractory gastroesophageal reflux disease.
    Fass R
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():3-7. PubMed ID: 22486864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An algorithm for diagnosis and treatment of refractory GERD.
    Hershcovici T; Fass R
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):923-36. PubMed ID: 21126704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights in the neural regulation of the lower oesophageal sphincter.
    Blackshaw LA
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():33-9. PubMed ID: 18924442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial.
    Boeckxstaens GE; Beaumont H; Hatlebakk JG; Silberg DG; Björck K; Karlsson M; Denison H
    Gut; 2011 Sep; 60(9):1182-8. PubMed ID: 21402616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: the clinical relevance of transient lower oesophageal sphincter relaxations in gastro-oesophageal reflux disease.
    Kessing BF; Conchillo JM; Bredenoord AJ; Smout AJ; Masclee AA
    Aliment Pharmacol Ther; 2011 Mar; 33(6):650-61. PubMed ID: 21219371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lesogaberan, a GABA(B) agonist for the potential treatment of gastroesophageal reflux disease.
    Bredenoord AJ
    IDrugs; 2009 Sep; 12(9):576-84. PubMed ID: 19697277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational gastrointestinal pharmacology in the 21st century: 'the lesogaberan story'.
    Boeckxstaens GE; Denison H; Jensen JM; Lehmann A; Ruth M
    Curr Opin Pharmacol; 2011 Dec; 11(6):630-3. PubMed ID: 22036168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial.
    Shaheen NJ; Denison H; Björck K; Karlsson M; Silberg DG
    Gut; 2013 Sep; 62(9):1248-55. PubMed ID: 22730470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatments of GERD: the old and new.
    Vela MF
    Gastroenterol Clin North Am; 2014 Mar; 43(1):121-33. PubMed ID: 24503363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.